9 studies found for:    382871 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting 1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain
Conditions: High Risk MC4R Genotype;   Low Risk MC4R Genotype;   One Week or Less Antipsychotic Lifetime Exposure
Interventions: Drug: Ziprasidone;   Drug: aripiprazole, quetiapine, or risperidone
2 Recruiting The Effects of Bariatric Surgeries on Non-Alcoholic Fatty Liver Disease
Conditions: Obesity.;   Non-Alcoholic Fatty Liver Disease.
3 Completed Caloric Restriction and Insulin Secretion
Conditions: Morbid Obesity;   Type 2 Diabetes Mellitus
Intervention: Behavioral: Very Low Calorie Diet
4 Completed
Has Results
Efficacy Study of Pioglitazone and Metformin and Association Between Pioglitazone Response and Peroxisome Proliferator-activated Receptor Gamma Gene Variants in Bangladeshi Type 2 Diabetes Mellitus Subjects
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Pioglitazone hydrochloride;   Drug: Metformin hydrochloride
5 Unknown  Metabolic Effects of Steroids in Obese Men
Conditions: Obesity;   Insulin Resistance
Interventions: Drug: Anastrazole;   Drug: Testosterone;   Drug: Dutasteride;   Drug: GnRH antagonist
6 Enrolling by invitation Beta Cell Function in (Pre) Type 1 Diabetes
Condition: Type 1 Diabetes
Intervention: Drug: glucose 20%
7 Completed Food and Insulin Effect on QT/QTC Interval of ECG
Conditions: Effects of Different Meals on the QT/QTc Interval;   Insulin Effects on the QT/QTc Interval;   C Peptide Effects on the QT/QTc Interval;   Moxifloxacin ECG Profile Fed and Fasted;   Japanese Caucasian TQT Comparison
Interventions: Drug: Placebo;   Other: FDA breakfast;   Other: Continental breakfast;   Drug: Moxifloxacin with food;   Drug: Moxifloxacin fasted;   Procedure: Insulin Clamp
8 Completed The Effects of Cocoa Flavanols on Insulin Resistance in an 'At-risk' Population
Condition: Insulin Resistance
Intervention: Dietary Supplement: Cocoa
9 Completed Effect of DMMET-01 on Insulin Sensitivity in Naive Type 2 Diabetes Patients (CLAMP)
Condition: Diabetes Type 2
Interventions: Drug: DMMET-01;   Drug: Placebo

Indicates status has not been verified in more than two years